Gentex kept 2026 revenue guidance at $2.65 billion-$2.75 billion; gross margin outlook raised to 34.5%-35.5%.
Operating expense forecast cut to $405 million-$415 million from $410 million-$420 million, excluding severance, impairments.
2027 revenue outlook lifted to $2.8 billion-$2.9 billion from $2.75 billion-$2.85 billion.
Capital expenditure view trimmed to $115 million-$125 million from $125 million-$140 million; depreciation, amortization held at $100 million-$110 million.
First-half net sales $1.33 billion; gross margin 35.4%; GAAP operating income $265 million.